Table 2.
Body Composition | Δ BCAA Group |
Δ Placebo Group |
Cases | F | p | η2 |
---|---|---|---|---|---|---|
Weight | −2.06 ± 3.9 | −3.3 ± 2.1 | Treatment | 8.645 | 0.004 | 0.052 |
Sex | 43.317 | <0.001 | 0.261 | |||
Fat free mass | 1.1 ± 1.2 | −0.5 ± 2.3 | Treatment * Sex | 17.866 | <0.001 | 0.108 |
Treatment | 62.246 | <0.001 | 0.392 | |||
Sex | 0.499 | 0.482 | 0.003 | |||
Treatment * Sex | 0.046 | 0.830 | 0.00029 | |||
Fat mass | −2.3 ± 2.5 | −2.7 ± 2.0 | Treatment | 1.130 | 0.290 | 0.011 |
Sex | 0.283 | 0.596 | 0.003 | |||
Muscle mass | 2.2 ± 1.3 | −0.6 ± 2.3 | Treatment * Sex | 3.106 | 0.081 | 0.031 |
Treatment | 53.970 | <0.001 | 0.354 | |||
Sex | 0.798 | 0.374 | 0.005 | |||
Treatment * Sex | 1.538 | 0.218 | 0.010 |
p by two-way ANOVA.